Article Information
PubMed
Print ISSN
Online ISSN
History
- Received September 4, 2012
- Accepted December 10, 2012
- Published online February 15, 2013.
Article Versions
- Earlier version (December 10, 2012 - 10:04).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2013 by The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Jessica A. Roseberry Baker1,
- Enaksha R. Wickremsinhe,
- Claire H. Li2,
- Olukayode A. Oluyedun3,
- Anne H. Dantzig4,
- Stephen D. Hall,
- Yue-wei Qian,
- Barbara J. Ring3,
- Steven A. Wrighton3, and
- Yingying Guo
- Drug Disposition (J.A.R.B., E.R.W., C.H.L., O.A.O., S.D.H., B.J.R., S.A.W., Y.G.), Oncology (A.H.D.), and Translational Sciences (Y.Q.), Eli Lilly and Company, Indianapolis, Indiana
- Address correspondence to:
Dr. Yingying Guo, Drug Disposition of Eli Lilly and Company, Drop Code 0714, Indianapolis, IN, 46285. E-mail: guoying{at}lilly.com
A portion of this work was presented at the at the following conference: Guo Y (2009) Gemcitabine pharmacogenomics: characterization of genetic variants of cytidine deaminase, 16th International Society for the Study of Xenobiotics Meeting; 2009 Oct 18–22; Baltimore, MD; and was published in abstract form: Guo Y (2009) Gemcitabine pharmacogenomics: characterization of genetic variants of cytidine deaminase. Drug Metab Rev 41 (Suppl 3):159.